Top Pharmaceutical Stocks To Watch Now - May 22nd - Defense World
Read Our Latest Research Report on QBTS
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
NYSE LLY traded down $5.93 on Thursday, hitting $719.02. 2,713,207 shares of the company were exchanged, compared to its average volume of 4,032,964. The firm has a market capitalization of $681.44 billion, a P/E ratio of 61.40, a price-to-earnings-growth ratio of 1.40 and a beta of 0.48. Eli Lilly and Company has a twelve month low of $677.09 and a twelve month high of $972.53. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.15 and a quick ratio of 0.97. The company’s 50 day moving average price is $793.65 and its 200-day moving average price is $804.27.
Read Our Latest Research Report on LLY
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of NYSE TMO traded up $1.53 during trading hours on Thursday, hitting $399.81. The stock had a trading volume of 1,674,894 shares, compared to its average volume of 2,313,924. The company has a market capitalization of $150.93 billion, a P/E ratio of 24.18, a P/E/G ratio of 2.99 and a beta of 0.82. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.29 and a current ratio of 1.66. The firm’s 50-day moving average price is $447.48 and its two-hundred day moving average price is $507.46. Thermo Fisher Scientific has a 52 week low of $390.49 and a 52 week high of $627.88.
